Validation of a non-invasive fluorescence imaging system to monitor dermatological PDT

Photodiagnosis and Photodynamic Therapy

Volumn 7, Issue 2, 2010, Pages 86-97

  Tyrrell, Jessica ^a   Campbell, Sandra ^a   Curnow, Alison ^a  

^a UNIVERSITY OF EXETER   (United Kingdom)

Author keywords

Dermatology; Fluorescence diagnosis (FD); Methyl aminolevulinate (MAL); Metvix ; Non invasive fluorescence imaging; Photodynamic therapy (PDT)

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER; PROTOPORPHYRIN; AMINOLEVULINIC ACID; METHYL 5-AMINOLEVULINATE; PHOTOSENSITIZING AGENT;

ACTINIC KERATOSIS; AGED; ARTICLE; CASE REPORT; COMPUTER PROGRAM; DERMATOLOGY; DIAGNOSTIC ACCURACY; FLUORESCENCE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MALE; NON INVASIVE PROCEDURE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REPRODUCIBILITY; SKIN DEFECT; SURGICAL TECHNIQUE; VALIDATION PROCESS; ANALOGS AND DERIVATIVES; DEVICES; DOSE RESPONSE; KERATOSIS, ACTINIC; PATHOLOGY; PHOTOCHEMOTHERAPY; PROCEDURES; SKIN; SKIN NEOPLASMS; STANDARDS; VALIDATION STUDY;

AGED; AMINOLEVULINIC ACID; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUORESCENCE; HUMANS; KERATOSIS, ACTINIC; MALE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROTOPORPHYRINS; REPRODUCIBILITY OF RESULTS; SKIN; SKIN NEOPLASMS;

EID: 77952674127     PISSN: 15721000     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2010.03.002     Document Type: Article

References (38)

1. Ackroyd R., Kelty C., Brown N., and Reed M. The history of photodetection and photodynamic therapy. Photochem Photobiol 74 (2001) 656-669
2. Sibata C.H., Colussi V.C., Oleinick N.L., and Kinsella T.J. Photodynamic therapy: a new concept in medical treatment. Braz J Med Biol Res 33 (2000) 869-880
3. Henderson B.W., and Dougherty T.J. How does photodynamic therapy work?. Photochem Photobiol 55 (1992) 145-157
4. Noodt B.B., Berg K., Stokke T., Peng Q., and Nesland J.M. Apoptosis and necrosis induced with light and 5-aminolaevulinic acid-derived protoporphyrin IX. BJC 74 (1996) 22-29
5. Calzavara-Pinton P.G., Venturini M., and Sala R. Photodynamic therapy: update 2006. Part 2. Clinical results. J European Acad Derm Vene 21 (2007) 439-451
6. Svanberg K., Andersson T., Killander D., et al. Photodynamic therapy of non-melanoma malignant tumours of the skin using topical delta-aminolevulinic acid sensitization and laser irradiation. BJD 130 (1994) 743-751
7. Malik Z., and Lugaci H. Destruction of erythroleukaemic cells by photoactivation of endogenous porphyrins. BJC 56 (1987) 589-595
8. Peng Q., Soler A.M., Warloe T., Nesland J.M., and Giercksky K.E. Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate. JPPB 62 (2001) 140-145
9. Peng Q., Berg K., Moan J., Kongshaug M., and Nesland J.M. 5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research. Photochem Photobiol 65 (1997) 235-251
10. Peng Q., Warloe T., Berg K., et al. 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer 79 (1997) 2282-2308
11. Morton C.A., Brown S.B., Collins S., et al. Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. BJD 146 (2002) 552-567
12. Moan J., Iani V., and Ma L.W. In: Benjamin E., Giulio J., and Moan J. (Eds). Choice of the proper wavelength for photochemotherapy (1996), SPIE 544-549
13. Scott M.A., Hopper C., Sahota A., et al. Fluorescence photodiagnosis and photobleaching studies of cancerous lesions using ratio imaging and spectroscopic techniques. Lasers Med Sci 15 (2000) 63-72
14. Wennberg A.M., Gudmundson F., Stenquist B., et al. In vivo detection of basal cell carcinoma using imaging spectroscopy. Acta Derm Venereol 79 (1999) 54-61
15. Ackermann G., Abels C., Karrer S., Baumler W., Landthaler M., and Szeimies R.M. Fluorescence-assisted biopsy of basal cell carcinomas. Hautarzt 51 (2000) 920-924
16. Siewecke C., and Szeimies R.M. PDT and fluorescence diagnosis in dermatology. Hosp Pharm Europe May/June (2004) 49-52
17. Bogaards A., Sterenborg H.J., Trachtenberg J., Wilson B.C., and Lilge L. In vivo quantification of fluorescent molecular markers in real-time by ratio imaging for diagnostic screening and image-guided surgery. Lasers Surg Med 39 (2007) 605-613
18. Smits T., Kleinpenning M.M., Blokx W.A., van de Kerkhof P.C., van Erp P.E., and Gerritsen M.J. Fluorescence diagnosis in keratinocytic intraepidermal neoplasias. J Am Acad Derm 57 (2007) 824-831
19. Bogaards A., Aalders M.C., Zeyl C.C., et al. Localization and staging of cervical intraepithelial neoplasia using double ratio fluorescence imaging. J Biomed Opt 7 (2002) 215-220
20. Hua Z., Gibson S.L., Foster T.H., and Hilf R. Effectiveness of delta-aminolevulinic acid-induced protoporphyrin as a photosensitiser for photodynamic therapy in vivo. Cancer Res 55 (1995) 1723-1731
21. Loh C.S., Vernon D., MacRobert A.J., Bedwell J., Bown S.G., and Brown S.B. Endogenous porphyrin distribution induced by 5-aminolaevulinic acid in the tissue layers of the gastrointestinal tract. JPPB 20 (1993) 47-54
22. Andersson-Engels S., Klinteberg C., Svanberg K., and Svanberg S. In vivo fluorescence imaging for tissue diagnostics. Phys Med Biol 42 (1997) 815-824
23. Boere I.A., Robinson D.J., de Bruijn H.S., et al. Monitoring in situ dosimetry and protoporphyrin IX fluorescence photobleaching in the normal rat esophagus during 5-aminolevulinic acid photodynamic therapy. Photochem Photobiol 78 (2003) 271-277
24. Ericson M.B., Sandberg C., Stenquist B., et al. Photodynamic therapy of actinic keratosis at varying fluence rates: assessment of photobleaching, pain and primary clinical outcome. BJD 151 (2004) 1204-1212
25. Loschenov V.B., Konov V.I., and Prokhorov A.M. Photodynamic therapy and fluorescence diagnostics. Laser Phys 10 (2000) 1188-1207
26. Berg K., Selbo P.K., Weyergang A., et al. Porphyrin-related photosensitizers for cancer imaging and therapeutic applications. J Microsc 218 (2005) 133-147
27. Smits T., Kleinpenning M.M., van Erp P.E., van de Kerkhof P.C., and Gerritsen M.J. A placebo-controlled randomized study on the clinical effectiveness, immunohistochemical changes and protoporphyrin IX accumulation in fractionated 5-aminolaevulinic acid-photodynamic therapy in patients with psoriasis. BJD 155 (2006) 429-436
28. Ascencio M., Collinet P., Farine M.O., and Mordon S. Protoporphyrin IX fluorescence photobleaching is a useful tool to predict the response of rat ovarian cancer following hexaminolevulinate photodynamic therapy. Lasers Surg Med 40 (2008) 332-341
29. Bogaards A., Sterenborg H.J., and Wilson B.C. In vivo quantification of fluorescent molecular markers in real-time: a review to evaluate the performance of five existing methods. Photodiagn Photodyn Ther 4 (2007) 170-178
30. Kleinpenning M.M., Smits T., Ewalds E., van Erp P.E., van de Kerkhof P.C., and Gerritsen M.J. Heterogeneity of fluorescence in psoriasis after application of 5-aminolaevulinic acid: an immunohistochemical study. BJD 155 (2006) 539-545
31. Martin A., Tope W.D., Grevelink J.M., et al. Lack of selectivity of protoporphyrin IX fluorescence for basal cell carcinoma after topical application of 5-aminolevulinic acid: implications for photodynamic treatment. Arch Derm Res 287 (1995) 665-674
32. Smits T., Robles C.A., van Erp P.E., van de Kerkhof P.C., and Gerritsen M.J. Correlation between macroscopic fluorescence and protoporphyrin IX content in psoriasis and actinic keratosis following application of aminolevulinic acid. J Invest Dermatol 125 (2005) 833-839
33. Anderson R.R., and Parrish J.A. The optics of human skin. J Invest Dermatol 77 (1981) 13-19
34. Bashkatov A.N., Genina E.A., Kochubey V.I., and Tuchin V.V. Optical properties of human skin, subcutaneous and mucous tissues in the wavelength range from 400 to 2000 nm. J Phys D: Appl Phys 38 (2005) 2543-2555
35. Robinson D.J., de Bruijn H.S., van der Veen N., Stringer M.R., Brown S.B., and Star W.M. Fluorescence photobleaching of ALA-induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: the effect of light dose and irradiance and the resulting biological effect. Photochem Photobiol 67 (1998) 140-149
36. Bech O., Berg K., and Moan J. The pH dependency of protoporphyrin IX formation in cells incubated with 5-aminolevulinic acid. Cancer Lett 113 (1997) 25-29
37. Bedwell J., MacRobert A.J., Phillips D., and Bown S.G. Fluorescence distribution and photodynamic effect of ALA-induced PP IX in the DMH rat colonic tumour model. BJC 65 (1992) 818-824
38. Berg K., Anholt H., Bech O., and Moan J. The influence of iron chelators on the accumulation of protoporphyrin IX in 5-aminolaevulinic acid-treated cells. BJC 74 (1996) 688-697